Best poster at ESMO 2017 shows positive trials twice as likely to be reported in lay press

(European Society for Medical Oncology) Randomized controlled trials with positive results are twice as likely to be reported by the lay press as those with negative trials, according to results from the Best Poster in Public Health and Health Economics at the ESMO 2017 Congress in Madrid. Trials on immunotherapy and targeted therapy were more commonly reported than those on chemotherapy.